Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Is Skechers Stock in a Coronavirus Quarantine Ahead of Q4?

Thanks to the enormous popularity of Skechers’ footwear and apparel, SKX stock would ordinarily be a buy right now. But nature has different ideas so staying on the sidelines is the better approach for now.

Forget Legalization: CBD Is Good Enough for CRON Stock

Under conventional thinking, CRON stock can’t reach its full potential without the U.S. fully legalizing weed. But the “dumbed-down” CBD market is really what the American consumer desires, which benefits Cronos via its Lord Jones acquisition.

Buy the Bloodshed in Twitter Stock After the Q4 Earnings Release

Twitter stock tumbled badly following the underlying company’s Q3 earnings report and unfortunately, Q4 may not be so hot either. But there are enough positives in this story to warrant a contrarian mindset.

7 Stocks to Buy for February Contrarians

Historically, the markets are very slow in February. But with a changing economy and geopolitical developments, this month may be a perfect time to consider stocks to buy.

Can You Trust the Second Act of BB Stock?

Based on its rough fiscal picture, it’s hard to recommend BB stock for conservative investors. But for contrarians not averse to risk, BlackBerry has an important take on the connected future.